Can pregnant women have mesotherapy?

No. Pregnancy is an absolute contraindication to mesotherapy. The safety of mesotherapy cocktail ingredients — including hyaluronic acid, various vitamins, and pharmaceutically active compounds — has not been established in pregnant populations. Mesotherapy must be postponed until after delivery and, if the patient is breastfeeding, until after cessation of breastfeeding.

Can people with autoimmune diseases have mesotherapy?

Active autoimmune disease is generally considered a relative contraindication. Patients with conditions such as lupus, rheumatoid arthritis, or psoriasis may be evaluated on an individual basis when the disease is in clinical remission and the treating physician deems the procedure safe. A specialist consultation is always required.

Does taking blood thinners prevent mesotherapy?

Anticoagulant therapy (warfarin, heparin) and dual antiplatelet therapy are relative contraindications due to the significantly increased risk of bruising and haematoma at injection sites. Low-dose aspirin and OTC supplements such as fish oil or vitamin E should ideally be paused 5–7 days before treatment, subject to the prescribing physician's approval.

Is mesotherapy safe for people with diabetes?

Well-controlled type 2 diabetes is not an absolute contraindication to mesotherapy, but it does require additional caution. Poor glycaemic control impairs wound healing, increases infection risk, and may alter the skin's response to active ingredients. The treating physician should assess HbA1c levels and ensure the diabetes is adequately managed before proceeding.

Mesotherapy Contraindications: Who Should Not Have Mesotherapy? 2026

Why Contraindications Matter in Mesotherapy

Mesotherapy contraindications are the medical conditions, physiological states, and medication combinations that preclude or necessitate special caution before undergoing mesotherapy. Because mesotherapy involves the transcutaneous delivery of pharmacologically active compounds directly into living tissue, candidate screening is not merely a formality — it is a fundamental patient safety step. A thorough pre-treatment consultation allows the physician to identify absolute contraindications (conditions where treatment must not be performed under any circumstances) and relative contraindications (conditions where treatment may be possible with modifications, additional precautions, or specialist approval).

Absolute Contraindications

The following conditions represent absolute contraindications to mesotherapy. Treatment must not be initiated under any of these circumstances:

Pregnancy and breastfeeding: The systemic safety of mesotherapy ingredients — including hyaluronic acid, vitamins, amino acids, enzymes, and pharmaceutical compounds such as phosphatidylcholine — has not been established in pregnant or lactating individuals. Mesotherapy must be postponed until after delivery and the complete cessation of breastfeeding.
Known allergy or hypersensitivity to any component of the mesotherapy cocktail to be used (e.g., lidocaine in anaesthetic preparations, specific vitamins, or procaine in certain protocols). A comprehensive allergy history must be obtained at consultation.
Active infection at or near the treatment site: Bacterial, viral (including active herpes simplex), or fungal infections in the treatment zone present an absolute barrier. Injecting through infected tissue risks disseminating pathogens deeper into the dermis or bloodstream.
Severe coagulation disorders: Conditions such as haemophilia or severe thrombocytopaenia (platelet count below 50,000/µL) are absolute contraindications due to the unacceptable risk of uncontrolled bleeding and haematoma formation.
Active malignancy: Patients undergoing treatment for cancer, or those with a recent diagnosis not yet in remission, should not receive mesotherapy until cleared by their oncologist. Certain mesotherapy cocktail ingredients have the theoretical potential to stimulate cellular growth.
Unstable systemic disease: Poorly controlled diabetes mellitus, recent myocardial infarction, decompensated heart failure, and uncontrolled hypertension represent absolute contraindications until medical stabilisation is achieved.

Relative Contraindications

Relative contraindications require careful individual assessment. Treatment may be possible with modifications or after obtaining specialist approval, but the decision must be made by a qualified physician on a case-by-case basis:

Autoimmune and Inflammatory Skin Diseases

Patients with systemic lupus erythematosus (SLE), rheumatoid arthritis, dermatomyositis, scleroderma, or active psoriasis are generally not candidates for mesotherapy during disease flares. The introduction of foreign substances into the dermis can provoke immune-mediated inflammatory responses. In patients whose disease is in confirmed clinical remission and who are on stable maintenance therapy, mesotherapy may be considered after discussion with the patient's rheumatologist or dermatologist.

Anticoagulant and Antiplatelet Therapy

Patients receiving warfarin, heparin, direct oral anticoagulants (DOACs) such as rivaroxaban or apixaban, or dual antiplatelet therapy face a substantially elevated risk of bruising, ecchymosis, and haematoma formation from needle-based procedures. Discontinuation of anticoagulants carries its own risks and must only be done under the supervision of the prescribing physician. For patients on therapeutic anticoagulation for atrial fibrillation, mechanical heart valves, or deep vein thrombosis, mesotherapy is typically deferred until treatment is complete or an alternative non-needle technique (needle-free mesotherapy) is discussed.

Over-the-counter supplements with blood-thinning properties — including high-dose fish oil, vitamin E, ginkgo biloba, and garlic supplements — should ideally be suspended 5–7 days before treatment, subject to the patient's primary care physician's approval.

Diabetes Mellitus

Well-controlled type 2 diabetes mellitus is not an absolute contraindication, but it requires heightened attention. Impaired wound healing, altered microvascular function, and increased susceptibility to infection in diabetic patients necessitate confirmation of satisfactory glycaemic control (HbA1c below 7.5–8% is a commonly used benchmark) before proceeding. Patients with peripheral neuropathy should be advised that pain perception during the procedure may be altered.

History of Keloid or Hypertrophic Scarring

A personal history of keloid formation or hypertrophic scarring is a relative contraindication, particularly for body mesotherapy or any application in areas of prior keloid development. Repeated needle trauma to the skin carries a risk of triggering abnormal scar tissue in predisposed individuals. The treating physician should document scar history and discuss risk with the patient before initiating treatment.

Immunosuppressive Therapy

Patients receiving systemic corticosteroids, methotrexate, biologics (e.g., TNF-alpha inhibitors), or post-transplant immunosuppressants have impaired immune responses that increase the risk of opportunistic infection following any needle-based procedure. Treatment requires coordination with the prescribing specialist.

Thyroid Disease

Uncontrolled hyperthyroidism or hypothyroidism affects wound healing and vascular response. Euthyroid status (normal thyroid function confirmed by recent blood tests) is recommended before mesotherapy is initiated, particularly for scalp hair mesotherapy protocols that include stimulating agents such as minoxidil alternatives or growth factors.

Active Acne or Rosacea Flare

Moderate-to-severe active acne vulgaris with multiple inflamed pustules, or an active rosacea flare with diffuse erythema and papulopustular lesions in the treatment zone, represents a relative contraindication. Injecting into inflamed tissue increases the risk of spreading bacteria and worsening inflammation. Treatment should be deferred until the skin condition is under control, typically with topical or systemic therapy.

Age Considerations

Mesotherapy is generally recommended for individuals aged 18 years and over. In adolescents, treatment may occasionally be considered for specific medical indications (such as alopecia areata) but requires parental or guardian consent and careful ethical consideration. Conversely, there is no absolute upper age limit; many patients over 60 benefit significantly from skin rejuvenation mesotherapy, provided that the systemic health precautions described above are observed.

Pre-Treatment Screening: What to Expect at Consultation

At Virtuana Clinic, every prospective mesotherapy patient undergoes a detailed pre-treatment assessment. This includes:

A comprehensive medical history covering current medications, allergies, chronic diseases, and prior aesthetic treatments
Skin type classification (Fitzpatrick scale) and assessment of the treatment area
Discussion of the specific mesotherapy cocktail ingredients to be used and their potential interactions
Review of any recent laboratory results (where relevant, e.g., blood count, coagulation studies, HbA1c)
Informed consent covering potential risks, contraindications, and the expected treatment course

Patients are encouraged to bring a complete and up-to-date list of all medications — including supplements, herbal products, and over-the-counter drugs — to their consultation appointment.

Conclusion

Identifying mesotherapy contraindications before treatment is as important as the procedure itself. A thorough candidate evaluation safeguards patient health, ensures that the treatment delivers its intended benefits, and prevents avoidable complications. If you are uncertain whether your health history or current medication regimen is compatible with mesotherapy, the safest course is always to arrange a formal consultation with a qualified physician before proceeding.

References

Mammucari M, Gatti A, Maggiori S, Sabato AF. "Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy." Evid Based Complement Alternat Med. 2012;2012:436959. [PubMed]
Sivagnanam G. "Mesotherapy — The French Connection." J Pharmacol Pharmacother. 2010;1(1):4-8. [PubMed]
DermNet NZ — Mesotherapy. [DermNet]
International Society of Mesotherapy — Clinical Guidelines. [ISM]

This article is for informational purposes only. Please consult a qualified physician for treatment decisions.